Vistagen Therapeutics CEO Shawn Singh's 2024 pay jumps 58% to $948K
Vistagen Therapeutics reports 2024 executive compensation
By ExecPay News
Published: April 15, 2024
Vistagen Therapeutics reported fiscal year 2024 executive compensation information on April 15, 2024.
In 2024, four executives at Vistagen Therapeutics received on average a compensation package of $656K, a 24% increase compared to previous year.
Average pay of disclosed executives at Vistagen Therapeutics
Shawn K. Singh, Chief Executive Officer, received $948K in total, which increased by 58% compared to 2023. 66% of Singh's compensation, or $623K, was in salary. Singh also received $325K in bonus.
Reid G. Adler, General Counsel, received a compensation package of $675K, which increased by 22% compared to previous year. 67% of the compensation package, or $450K, was in salary.
Joshua S. Prince, Chief Operating Officer, earned $568K in 2024.
Cynthia L. Anderson, Chief Financial Officer, received $434K in 2024.
Vistagen Therapeutics' fiscal year ends on March 31.
Related executives
You may also like
Source: SEC filing on April 15, 2024.